Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 237
mi
from 98109
Houston, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 237
mi
from 98109
Houston, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 419
mi
from 98109
Houston, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 419
mi
from 98109
Houston, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 726
mi
from 98109
Houston, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 726
mi
from 98109
Houston, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 312
mi
from 98109
Pasadena, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 312
mi
from 98109
Pasadena, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 657
mi
from 98109
San Antonio, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 657
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 923
mi
from 98109
San Antonio, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 923
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 279
mi
from 98109
Southlake, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 279
mi
from 98109
Southlake, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 366
mi
from 98109
Temple, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 366
mi
from 98109
Temple, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 539
mi
from 98109
Tyler, TX
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 539
mi
from 98109
Tyler, TX
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 986
mi
from 98109
Salt Lake City, UT
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 986
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 814
mi
from 98109
Burlington, VT
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 814
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 963
mi
from 98109
Colchester, VT
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 963
mi
from 98109
Colchester, VT
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 675
mi
from 98109
Christiansburg, VA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 675
mi
from 98109
Christiansburg, VA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 691
mi
from 98109
Norfolk, VA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 691
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 446
mi
from 98109
Richmond, VA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 446
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 026
mi
from 98109
Virginia Beach, VA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 026
mi
from 98109
Virginia Beach, VA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 273
mi
from 98109
Woodbridge, VA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 273
mi
from 98109
Woodbridge, VA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 471
mi
from 98109
Seattle, WA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 471
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 925
mi
from 98109
Tacoma, WA
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 925
mi
from 98109
Tacoma, WA
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 465
mi
from 98109
Green Bay, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 465
mi
from 98109
Green Bay, WI
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 116
mi
from 98109
Madison, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 116
mi
from 98109
Madison, WI
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 070
mi
from 98109
Milwaukee, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 070
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 281
mi
from 98109
Milwaukee, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 281
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 389
mi
from 98109
Milwaukee, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 389
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 578
mi
from 98109
Milwaukee, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 578
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
C87075 093
mi
from 98109
Oshkosh, WI
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
C87075 093
mi
from 98109
Oshkosh, WI
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1821
mi
from 98109
Shreveport, LA
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1821
mi
from 98109
Shreveport, LA
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2377
mi
from 98109
Morristown, NJ
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2377
mi
from 98109
Morristown, NJ
Click here to add this to my saved trials
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated:  12/31/1969
Research Site
8190
mi
from 98109
Parkville,
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
An Open-label, Multicenter Study to Assess the Safety of Certolizumab Pegol in Children and Adolescents With Active Crohn's Disease Who Completed C87035 (NCT00899678) or Who Were Terminated From C87035
Status: Enrolling
Updated: 12/31/1969
Research Site
8190
mi
from 98109
Parkville,
Click here to add this to my saved trials
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated:  12/31/1969
Saint Mary Medical Center
1761
mi
from 98109
Hobart, IN
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated: 12/31/1969
Saint Mary Medical Center
1761
mi
from 98109
Hobart, IN
Click here to add this to my saved trials
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated:  12/31/1969
Livingston Hospital and Healthcare Services, Inc. CAH
1860
mi
from 98109
Salem, KY
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated: 12/31/1969
Livingston Hospital and Healthcare Services, Inc. CAH
1860
mi
from 98109
Salem, KY
Click here to add this to my saved trials
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated:  12/31/1969
Allegan Surgical Associates
1796
mi
from 98109
Allegan, MI
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated: 12/31/1969
Allegan Surgical Associates
1796
mi
from 98109
Allegan, MI
Click here to add this to my saved trials
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated:  12/31/1969
Ihde Surgical Group, PA
1673
mi
from 98109
Arlington, TX
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated: 12/31/1969
Ihde Surgical Group, PA
1673
mi
from 98109
Arlington, TX
Click here to add this to my saved trials
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated:  12/31/1969
Reston Surgical Associates
2305
mi
from 98109
Reston, VA
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
Long-term Outcomes After Transoral Incisionless Fundoplication (TIF) Performed in Routine Clinical Practice: The Retro TIF Study
Status: Enrolling
Updated: 12/31/1969
Reston Surgical Associates
2305
mi
from 98109
Reston, VA
Click here to add this to my saved trials
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated:  12/31/1969
Scripps Clinic & Research Foundation
979
mi
from 98109
La Jolla, CA
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated: 12/31/1969
Scripps Clinic & Research Foundation
979
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
2180
mi
from 98109
Atlanta, GA
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
2401
mi
from 98109
New York, NY
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Comparison of Two Different Pain Management Techniques in Pediatric Patients Undergoing a Hernia Repair
Randomized Prospective Comparison of Analgesic Efficacy of Surgeon Performed IIlioinguinal/Iliohypogastric Blockade With Ultrasound-Guided TAP Blockade in Pediatric Patients Undergoing Unilateral Herniorrhaphy on an Outpatient Basis
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hosptial Medical Center - Liberty Campus
1967
mi
from 98109
Cincinnati, OH
Comparison of Two Different Pain Management Techniques in Pediatric Patients Undergoing a Hernia Repair
Randomized Prospective Comparison of Analgesic Efficacy of Surgeon Performed IIlioinguinal/Iliohypogastric Blockade With Ultrasound-Guided TAP Blockade in Pediatric Patients Undergoing Unilateral Herniorrhaphy on an Outpatient Basis
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hosptial Medical Center - Liberty Campus
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Dane County Drug Court Study for Addicted Offenders
Health Promotion and Public Safety: Community-based Collaborative Services to Addicted Offenders
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Department of Family Medicine
1617
mi
from 98109
Madison, WI
Dane County Drug Court Study for Addicted Offenders
Health Promotion and Public Safety: Community-based Collaborative Services to Addicted Offenders
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Department of Family Medicine
1617
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Cone Beam CT (CS 9300) for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Medical Center
2329
mi
from 98109
Baltimore, MD
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Cone Beam CT (CS 9300) for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Medical Center
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Cone Beam CT (CS 9300) for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Status: Enrolling
Updated:  12/31/1969
Sint-Augustinus Hospital
4914
mi
from 98109
Antwerp,
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Cone Beam CT (CS 9300) for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
Status: Enrolling
Updated: 12/31/1969
Sint-Augustinus Hospital
4914
mi
from 98109
Antwerp,
Click here to add this to my saved trials
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Status: Enrolling
Updated:  12/31/1969
White River Junction VAMC
2389
mi
from 98109
White River Junction, VT
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
Status: Enrolling
Updated: 12/31/1969
White River Junction VAMC
2389
mi
from 98109
White River Junction, VT
Click here to add this to my saved trials
A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials